FDA Orange Book
Is there a generic for Velsipity?
Velsipity contains etrasimod. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Velsipity (etrasimod). The Orange Book shows its last listed patent expires June 21, 2036 and its last listed exclusivity ends October 12, 2028.
Run it in Rivvi
Map Velsipity and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Velsipity products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | EQ 2MG BASE | Marketed (Rx) | None | 0 | None |
NDA 216956, held by PFIZER INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Velsipity patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9126932 | July 22, 2029 | Method of use | U-3732 | 216956 |
| 8580841 | March 5, 2030 | Drug substance, Drug product | None | 216956 |
| 12377071 | January 6, 2036 | Method of use | U-4255 | 216956 |
| 11007175 | January 6, 2036 | Method of use | U-3730 | 216956 |
| 12156866 | January 6, 2036 | Method of use | U-4047 | 216956 |
| 11884626 | June 21, 2036 | Method of use | U-3731 | 216956 |
| 10676435 | June 21, 2036 | Method of use | U-3731 | 216956 |
| 11091435 | June 21, 2036 | Drug substance, Drug product | None | 216956 |
| 10301262 | June 21, 2036 | Drug substance, Drug product | None | 216956 |
Velsipity exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | October 12, 2028 | 216956 |
Velsipity NDC codes
Questions
Is there a generic for Velsipity?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Velsipity (etrasimod). The Orange Book shows its last listed patent expires June 21, 2036 and its last listed exclusivity ends October 12, 2028.
What is the generic name for Velsipity?
The active ingredient in Velsipity is etrasimod, per the FDA Orange Book.
When does the Velsipity patent expire?
The last patent listed for Velsipity in the Orange Book expires June 21, 2036. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.